AmeRuss Clinical Trials, LLC

Crown CRO is a privately owned Finnish CRO founded in 2005. Our headquarters are in Espoo, which is located in Finland’s capital city region. Crown CRO offices are located in Finland, Sweden, Denmark, Norway, Estonia, Latvia and Lithuania. We have ongoing trials managed by our employees in Netherlands, Belgium, UK, Iceland, Ukraine and Belarus. Rest of the Europe and USA we cover through our qualified CRO network.

Our services cover Phase I – IV clinical development from protocol design to final reporting or any parts of the trial in various business models. Data services, Regulatory consulting, Pharmacovigilance, QA, Study Rescue Services and Medical Translation services complete the service package.

Our key therapeutic areas include, but not limited to, CNS, Oncology, Endocrinology, Cardiovascular, Respiratory and Musculoskeletal. We also have strong recent experience in Medical Devices from various indications.

Our passion for research across all our in-house Full-Service functions provide effective and innovative solutions with seamless cooperation for Phase I-III trials in Europe offering special focus on Nordic-Baltic area, together with our own Global Data Services ensuring consistency regardless of where your trials are located, offer you unrivalled customer attention, flexibility and high local level expertise which are key assets you can count on.

See www.crowncro.com for more information.

Fountain Medical Development is a clinical contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services in China, US, Japan, and Europe. FMD has extensive global experience in multiple therapeutic areas. The company has completed dozens of registrations trials which supported marketing authorization applications in US and Europe.

Our people is the basis of our success. The 1,700+ professionals are dedicated and diverse. At any given moment, at least 3 languages are spoken in our 20 offices in Asia, US, and Europe.

FMD is on the forefront of the paradigm shift in global clinical development. The regulatory reform in China has the potential to fundamentally change how an innovative therapy is developed. FMD is on the frontline building and shaping the future.

FMD is large enough to serve 7 out the 10 largest Pharma companies, and nimble enough to customize to the needs of startup firms.

In the US and Europe, FMD is doing business as FMD K&L. In China, we operate under the name FMD. Whatever the names are, the company is managed globally by a seasoned senior management team comprised of industry veterans.

Together we build a bright future.

IRW is a Nordic full-service Clinical Research Organization (CRO) with more than 20 years experience and we are established in local offices in Stockholm, Gothenburg, Oslo, Copenhagen and Helsinki.

The IRW team is dedicated and professional, with a wide range of academic competence and solid experience of clinical research, Pharmacovigilance, Data Management and Biostatistics, as well as of working with global pharmaceutical and biotech companies, and of interacting with the various regulatory authorities in the Nordic region.

We can manage your project from start to finish, or function as a fully-integrated part of your team.

In all Nordic countries, experienced native-speaking experts handle all regulatory and ethical submissions, as well as local literature search, monitoring services and support to site etc. This, together with an excellent network, will speed up the regulatory processes, as well as facilitating communications with authorities, sites and investigators/physicians.

Being a local Nordic CRO, we can provide you with our wide-ranging knowledge on local requirements and local networks.

Please feel free to contact us for a dialogue regarding your clinical trial needs at +46 8 791 66 40.

Neox is a privately owned full services clinical CRO. We conduct clinical trials for pharmaceutical, biotechnology, medical device companies and other CRO’s throughout Europe. Our services are offered for Phase I-IV.

As of 2020, Neox is an Emmes company. A global, full-service Clinical Research Organization dedicated to excellence in supporting the advancement of public health and biopharmaceutical innovation.

DRUG DEVELOPMENT - Medical Writing, Site Contracting, Clinical Monitoring, Project Management, Pharmacovigilance, Regulatory, Medical Monitoring, Outsourcing.
MEDICAL DEVICE DEVELOPMENT
PHARMACOVIGILANCE & REGULATORY
REAL WORLD EVIDENCE/DATA & HEOR
DATA MANAGEMENT & BIOSTATISTICS

We offer our services as a full service package or individually as a tailored solution to your specific needs.

Where We Are
Years of clinical research experience, understanding local requirements and established relationships with investigators ensures that your trial will always be performed in an optimal setting for high patient enrollment.

Neox offices: Czechia, California, Germany, Poland, Hungary, Bulgaria, Slovakia.

Neox also operates in: Austria, Belgium, Estonia, France, Finland, Italy, Latvia, Lithuania, Netherlands, Spain, United Kingdom and others.

Contact us at:

tel: +420 241 400 761
email: info@neoxcro.com
www.neoxcro.com

We are a global healthcare intelligence partner, consistently ranked among the top CROs and best employers worldwide.
We help develop life-saving and life-improving drugs with our comprehensive clinical development services, including data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting.